Pediatrix Medical Group Inc   (MD)
Other Ticker:  
    Sector  Healthcare    Industry Healthcare Facilities
   Industry Healthcare Facilities
   Sector  Healthcare
Price: $7.4600 $-0.13 -1.713%
Day's High: $7.7 Week Perf: 0.00
Day's Low: $ 7.45 30 Day Perf: -16.18 %
Volume (M): 647 52 Wk High: $ 15.02
Volume (M$): $ 4,824 52 Wk Avg: $11.03
Open: $7.65 52 Wk Low: $7.26

 Market Capitalization (Millions $) 619
 Shares Outstanding (Millions) 83
 Employees 8,200
 Revenues (TTM) (Millions $) 2,012
 Net Income (TTM) (Millions $) 94
 Cash Flow (TTM) (Millions $) 13
 Capital Exp. (TTM) (Millions $) 33

Pediatrix Medical Group Inc
Pediatrix Medical Group Inc (now known as MEDNAX) is a leading provider of specialized healthcare services focused on providing high-quality, comprehensive care to newborns, children and women. The company was established in 1979 in Fort Lauderdale, Florida, and has since grown to become the largest provider of neonatal and maternal-fetal care services in the United States.

The company's business model is built around providing a wide range of specialized medical services to hospitals and healthcare providers across the country, including neonatal care, pediatric cardiology, neurology, anesthesiology, radiology, and maternal-fetal medicine. Pediatrix Medical Group is dedicated to improving patient outcomes and providing quality care to ensure the health and well-being of newborns, children, and women.

Additionally, Pediatrix Medical Group is committed to clinical research and technological advancements in the field. The company has an extensive clinical database of patient outcomes, which enables them to identify patterns and improve patient care outcomes. The group maintains a strong focus on medical education and has an extensive training program for their healthcare professionals.

Today, Pediatrix Medical Group is a part of MEDNAX, a national medical solutions provider that operates in all 50 states. With over 9,000 clinicians who care for over 8 million patients annually, MEDNAX is dedicated to providing exceptional care and improving outcomes for patients across the healthcare continuum.

   Company Address: 1301 Concord Terrace Sunrise 33323 FL
   Company Phone Number: 384-0175   Stock Exchange / Ticker: NYSE MD


Stock Performances by Major Competitors

5 Days Decrease / Increase
• View Complete Report

Pediatrix Medical Group Inc

Pediatrix Medical Group Inc Faces Profit Decline Despite Surge in Business at the MD

Pediatrix Medical Group Inc Reports Declining EPS but Increasing Revenue in Q3 2023

In the financial interval closing on September 30, 2023, Pediatrix Medical Group Inc (MD) has disclosed declining earnings per share (EPS) despite an increase in revenue. The healthcare company achieved revenue growth of 3.408% to $506.61 million, compared to $489.92 million in the same period last year. However, earnings per share dropped by -29.73% to $0.26 per share, compared to $0.37 in the corresponding interval the previous year.
To fully analyze MD's third quarter of 2023 results, investors must also consider the performance of other companies within the Healthcare Facilities sector. It is evident that MD has underperformed, as its peers reported a top-line rise of 7.30% from the third quarter of 2022. In the prior reporting period, MD achieved revenue of $500.58 million and a bottom line of $0.34 per share.

Pediatrix Medical Group Inc

Pediatrix Medical Group Inc Reports a 6.25% Surge in EPS amidst Marginal Revenue Growth in Q2 2023, Despite Underperforming within the Healthcare Facilities Industry

Pediatrix Medical Group Inc, a prominent healthcare facility, recently published their financial results for the second quarter of 2023. While the company experienced a moderate revenue rise and increased income per share, their performance in comparison to industry peers raises concerns. This article aims to interpret these results and speculate on how they might impact Pediatrix Medical Group Inc in the future.
Financial Performance and Industry Comparison:
In the second quarter of 2023, Pediatrix Medical Group Inc reported a revenue increase of 2.992% to $500.58 million. Furthermore, their income per share surged by 6.25% to $0.34 compared to the previous year. However, when compared to its contemporaries in the Healthcare Facilities industry, Pediatrix Medical Group Inc has underachieved. Industry peers reported a top-line rise of 8.32% in Q2 of 2022, highlighting potential areas for improvement.

Pediatrix Medical Group Inc

The markets are digesting the 1.821%, boost at Pediatrix Medical Group Inc over the fiscal period ending March 31 2023



Pediatrix Medical Group Inc's Segments
• View Complete Report


About us


CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2024 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com